Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor. | Immunother Adv | 2022 | 36196369 | PubTator, text mining | PubMed |
| The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application. | Front Immunol | 2022 | 36189293 | PubTator, text mining | PubMed |
| Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental development and preeclampsia. | Front Cell Dev Biol | 2022 | 36187484 | PubTator, text mining | PubMed |
| Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. | Front Med (Lausanne) | 2022 | 36186781 | PubTator, text mining | PubMed |
| Structural analysis of human CEACAM1 oligomerization. | Commun Biol | 2022 | 36180783 | PubTator, text mining | PubMed |
| Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers. | Front Immunol | 2022 | 36172359 | PubTator, text mining | PubMed |
| Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. | J Immunother Cancer | 2022 | 36171009 | PubTator, text mining | PubMed |
| Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy. | Front Immunol | 2022 | 36159789 | PubTator, text mining | PubMed |
| Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. | World J Gastroenterol | 2022 | 36159004 | PubTator, text mining | PubMed |
| The role of long non-coding RNA ANRIL in the development of atherosclerosis. | Noncoding RNA Res | 2022 | 36157350 | PubTator, text mining | PubMed |
| The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma. | Front Oncol | 2022 | 36147906 | PubTator, text mining | PubMed |
| Integration of TE Induces Cancer Specific Alternative Splicing Events. | Int J Mol Sci | 2022 | 36142830 | PubTator, text mining | PubMed |
| Cancer Resistance to Immunotherapy: Molecular Mechanisms and Tackling Strategies. | Int J Mol Sci | 2022 | 36142818 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer. | Int J Mol Sci | 2022 | 36142451 | PubTator, text mining | PubMed |
| The Features of Checkpoint Receptor-Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. | Biomedicines | 2022 | 36140182 | PubTator, text mining | PubMed |
| Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells. | Biomolecules | 2022 | 36139097 | PubTator, text mining | PubMed |
| Distribution of Coronavirus Receptors in the Swine Respiratory and Intestinal Tract. | Vet Sci | 2022 | 36136717 | PubTator, text mining | PubMed |
| Emerging Trends in Immunotherapy for Cancer. | Diseases | 2022 | 36135216 | PubTator, text mining | PubMed |
| Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting. | Immunity | 2022 | 36130603 | PubTator, text mining | PubMed |
| Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis. | Front Oncol | 2022 | 36119470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=33